The Japanese pharmaceutical firm saw its revenue dip slightly to 45.50 billion yen, compared to 45.83 billion yen in the prior year. Operating performance faced significant pressure, resulting in an operating profit of 1.69 billion yen, a stark reversal from the 6.84 billion yen loss recorded in the previous corresponding period. Pretax profit also retreated to 2.92 billion yen from 5.62 billion yen. These results, prepared under Japanese accounting standards, translate to earnings per share of 124.88 yen, down from 186.81 yen reported in 2025.
Kissei Pharmaceutical Net Profit Slides to 5.19 Billion Yen
Kissei Pharmaceutical Co. Ltd. reported a sharp contraction in earnings for the first half of the fiscal year ending September 30, with net profit falling to 5.19 billion yen from 7.78 billion yen during the same period last year, according to the company’s latest financial disclosure.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!